Ctu सार्वजनिक
[search 0]
अधिक
Download the App!
show episodes
 
Artwork
 
Jsem to, co čtu, a tohle je můj čtenářský deník. Jmenuju se Robert Vlach a knihy mají v mém životě důležité místo. Přes čtenářský blog je můžete objevovat spolu se mnou. Jednu knihu (Na volné noze: Podnikejte jako profesionálové) jsem také napsal. Anglicky vyšla jako The Freelance Way. Jinak jsem na volné noze jako podnikatelský poradce.
  continue reading
 
Artwork

1
MRC CTU Podcasts

MRC Clinical Trials Unit at UCL

Unsubscribe
Unsubscribe
मासिक
 
The Trial Talk podcast explores how our work at the MRC Clinical Trials Unit at UCL is improving health in the UK and worldwide. In this series, we hear from world-leading experts about the studies we carry out. We delve into trials on cancer, infections and neurodegenerative diseases, explore how public and patient involvement shapes our work, and discover new ways to run smarter studies.
  continue reading
 
Loading …
show series
 
Audiorecenze naprosto mimořádného románu, který je vedle skvěle namluvené anglické audioknihy naštěstí dostupný i v českém překladu jako Šántárám. Viz také můj komentář v angličtině: If you’d ask me today what’s the greatest novel of the 21st century, I’d be tempted to say it’s Shantaram, written by Gregory David Roberts in 2004. The book, recommen…
  continue reading
 
UKCTOCS (UK Collaborative Trial of Ovarian Cancer Screening) is one of the largest screening trials in ovarian cancer. More than 200,000 women from England, Wales and Northern Ireland took part in it, and it ran for almost two decades. Designing and running such a large and lengthy trial came with its own challenges. In this episode, Professor Usha…
  continue reading
 
In the first episode of our new Trial Talk series, Hanif Esmail and Conor Tweed take over the microphones to interview Andrew Nunn and Sarah Meredith, who have both recently retired from the Unit, having spent a combined total of 92 years working in the field of tuberculosis (TB). As we celebrate Andrew and Sarah’s long and accomplished careers, we…
  continue reading
 
Every year on 1st December, we mark World AIDS Day to show solidarity in the fight against HIV and AIDS, and to remember those who have sadly lost their lives. Since the start of the global AIDS epidemic in the 1980s, researchers have made enormous progress towards preventing HIV transmission, and treating those who are living with HIV so that the …
  continue reading
 
Every year on 1st December, we mark World AIDS Day to show solidarity in the fight against HIV and AIDS, and to remember those who have sadly lost their lives. Since the start of the global AIDS epidemic in the 1980s, researchers have made enormous progress towards preventing HIV transmission, and treating those who are living with HIV so that the …
  continue reading
 
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recrui…
  continue reading
 
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recrui…
  continue reading
 
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recrui…
  continue reading
 
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC CTU at UCL. Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recruiting participants…
  continue reading
 
Innovative platform designs present an opportunity to run faster and more efficient clinical trials. Clinical trials methodology is a research area that looks at how to improve the design, conduct, and analysis of clinical trials. It focuses on developing and implementing new methods to help run trials faster and more efficiently, that will ultimat…
  continue reading
 
Audiorecenze jedné z nejdůležitějších knih tohoto roku! Zároveň jde o volné pokračování zásadní knihy o putinovském režimu Všetci mocní Kremľa (All the Kremlin’s Men) od stejného autora — tentokrát s podtitulem The Story of Russian Oppression and Ukrainian Resistance.
  continue reading
 
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different treatments and directly led to improvements in the standard of prostate cancer care several times. This Trial Talk podcast mini-series will explore the tria…
  continue reading
 
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different treatments and directly led to improvements in the standard of prostate cancer care several times. This Trial Talk podcast mini-series will explore the tria…
  continue reading
 
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different treatments and directly led to improvements in the standard of prostate cancer care several times. This Trial Talk podcast mini-series will explore the tria…
  continue reading
 
Immunotherapy drugs fight cancer by helping the immune system recognise and attack cancer cells. These drugs have revolutionised cancer treatment over the last decade, improving survival for many people with different types of cancer. However, researchers are still unsure of the best way to give immunotherapy, which can come with unpredictable side…
  continue reading
 
Running a clinical trial means collecting a lot of data from the trial participants. But some of this data might be collected and stored in healthcare systems, as well as in clinical trial case report forms. What if we could avoid this doubling up, save time and resources, improve recruitment and reduce missing data? In this episode we explore the …
  continue reading
 
On this episode of CTU Speaks!, co-hosts Andrea Parker and Jim Staros bring a crew into the studio from the We Care New Teachers/Clinicians Coaching and Mentoring Program, which is a union-led, CTU initiative in partnership with CPS. We Care provides mentoring and support to educators in their first three years to help them navigate the various cha…
  continue reading
 
Neonatal sepsis is a life-threatening infection that affects up to 3 million babies per year globally. In an effort to identify better treatments, the NeoSep1 clinical trial evaluates new antibiotic combinations for newborn babies with sepsis. To learn more about the trial, we speak to Adrie Bekker and Cristina Obiero, principal investigators of th…
  continue reading
 
214,000 newborn babies die of sepsis caused by infections that are resistant to antibiotics every year. This is a major problem worldwide, but disproportionally affects low- and middle- income countries.Reenu Thomas and Adrie Bekker, two neonatologists from South Africa, and Francesca Schiavone, clinical project manager at the MRC CTU at UCL in Lon…
  continue reading
 
Loading …

त्वरित संदर्भ मार्गदर्शिका